Armenia
Review Article
Performance Characteristics of GenXpert MTB/rif in Armenia
Author(s): Armen Hayrapetyan, Hasmik Margaryan and Aram ManukyanArmen Hayrapetyan, Hasmik Margaryan and Aram Manukyan
Global TB control efforts have been severely hampered by the lack of diagnostic tests that are accurate, simple to use and can be applied at the point of clinical care. This has been further compounded by the widespread inability to test for drug resistance. We estimated the performance Characteristics of GenXpert MTB/rif of an active case finding program in Armenia where TB notifications is high. Armenia remains in the top ten out of the 27 high multidrug-resistant (MDR) TB burden countries in the world. According to the latest representative 2007 Drug Resistance Survey (DRS) 9.4% of new cases and 43.2% of previously treated cases were multi-drug resistant. Of these, 4% were extensively-drug-resistant tuberculosis (XDR/TB) cases. Detection of MDR-TB in Armenia remains at 37%. Despite of the fact that in 2013 all detected MDR-TB cases were enrolled in MDR-TB treatment.. Read More»
DOI:
10.4172/2161-105X.1000348
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report